03-20-2018 New SHIKARI® Q-ATI DUO ELISA kit for Infliximab(Remicade®)
01-10-2018 New SHIKARI® Q-AVE and S-ATAV(anti PD-L1) ELISA kits for Avelumab(Bavencio®)and Anti-Avelumab antibodies!
12-30-2017 Kit performance of the SHIKARI Q-TRAS ELISA kit for measuring trastuzumab in serum/plasma samples.
12-08-2017 New products from MATRIKS BIOTEK! New SHIKARI® ELISA kits for Total Antibody detection to Infliximab (Remicade®), Infliximab biosimilar (Remsima®) and Adalimumab (Humira®)
11-28-2017 New article. SHIKARI® Q-CETUX ELISA kit have been used to measure cetuximab levels in a comparative study with a new method utilizing LC-MS/MS method and validated accordingly
11-24-2017 New SHIKARI® ELISA kits for total anti-drug antibodies to Infliximab, Infliximab-biosimilar, CT-P13 and Adalimumab will be launched very soon!
11-21-2017 New publication Johannes Gojo, Robert Sauermann, Ursula Knaack, Irene Slave, Andreas Peyrl, Pharmacokinetics of Bevacizumab in Three Patients Under the Age of 3 Years with CNS Malignancies. Drugs R D 17:469-474, 2017
09-09-2017 Our new distributors; IWAI JAPAN and USA, BioChemMack JCS Russia
07-27-2017 5 New publications are added; 2 patents, 2 peer reviewed articles and 1 PhD thesis.
07-10-2017 five new products for Pembrolizumab(Keytruda®),Ipilimumab(Yervoy®) and Filgrastim,